144 related articles for article (PubMed ID: 10837791)
21. Hepatoprotective effects of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] on alcohol-damaged primary rat hepatocyte culture in vitro.
Jiang W; Bian Y; Wang Z; Chang TM
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):46-50. PubMed ID: 27263665
[TBL] [Abstract][Full Text] [Related]
22. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
Gao W; Bian Y; Chang TM
Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597
[TBL] [Abstract][Full Text] [Related]
23. Superoxide generation from human polymorphonuclear leukocytes by liposome-encapsulated hemoglobin.
Abe H; Ikebuchi K; Niwa K; Inanami O; Kuwabara M; Fujihara M; Hirayama J; Ikeda H
Artif Cells Blood Substit Immobil Biotechnol; 2001 Jul; 29(4):275-83. PubMed ID: 11495009
[TBL] [Abstract][Full Text] [Related]
24. Effects of intravenous superoxide dismutase and catalase on electroretinogram in the cat postischemic retina.
Yamamoto F; Hiroi K; Honda Y
Ophthalmic Res; 1994; 26(3):163-8. PubMed ID: 8090434
[TBL] [Abstract][Full Text] [Related]
25. Nanobiotechnology for hemoglobin-based blood substitutes.
Chang TM
Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914
[TBL] [Abstract][Full Text] [Related]
26. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
Bian Y; Rong Z; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
[TBL] [Abstract][Full Text] [Related]
27. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
Chang TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):418-30. PubMed ID: 20564467
[TBL] [Abstract][Full Text] [Related]
28. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.
Guo C; Chang TMS
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1349-1363. PubMed ID: 29873524
[TBL] [Abstract][Full Text] [Related]
29. Artificial blood: ancient dream, modern enigma.
Winslow RM
Nat Biotechnol; 1998 Jul; 16(7):621-2. PubMed ID: 9661191
[No Abstract] [Full Text] [Related]
30. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
Gu J; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):69-77. PubMed ID: 19229698
[TBL] [Abstract][Full Text] [Related]
31. Effect of modified polyhemoglobin on the ischemia/reperfusion injury in kidney.
Mun KC; Lee HG; Lee TH; Kim YH; Kwak CS; Kim SP; Chang EJ; Park SB; Kim HC
Transplant Proc; 2003 Feb; 35(1):99-100. PubMed ID: 12591324
[No Abstract] [Full Text] [Related]
32. Future generations of red blood cell substitutes.
Chang TM
J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
[TBL] [Abstract][Full Text] [Related]
33. Enzymatic protection from autoxidation for crosslinked hemoglobins.
Yang T; Olsen KW
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):709-17. PubMed ID: 7994392
[TBL] [Abstract][Full Text] [Related]
34. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
[TBL] [Abstract][Full Text] [Related]
35. Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release.
D'Agnillo F; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):609-21. PubMed ID: 8117850
[TBL] [Abstract][Full Text] [Related]
36. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts.
Tosaki A; Droy-Lefaix MT; Pali T; Das DK
Free Radic Biol Med; 1993 Apr; 14(4):361-70. PubMed ID: 8385645
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of catalase and superoxide dismutase to macrophages using folate.
Lee S; Murthy N
Biochem Biophys Res Commun; 2007 Aug; 360(1):275-9. PubMed ID: 17586472
[TBL] [Abstract][Full Text] [Related]
38. Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery.
Giovagnoli S; Blasi P; Ricci M; Rossi C
AAPS PharmSciTech; 2004 Oct; 5(4):e51. PubMed ID: 15760048
[TBL] [Abstract][Full Text] [Related]
39. Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction. Polyethylene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs.
Tanaka M; Stoler RC; FitzHarris GP; Jennings RB; Reimer KA
Circ Res; 1990 Sep; 67(3):636-44. PubMed ID: 2397573
[TBL] [Abstract][Full Text] [Related]
40. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.
Yu WP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):169-83. PubMed ID: 8773737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
